batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Bristol nips at Roche’s heels in the subcutaneous PD-1 race 20 October 2023 ESMO 2023 – Amgen keeps tarlatamab filing plans under wraps 20 October 2023 ESMO 2023 – Roche heralds "unprecedented" Alecensa data 18 October 2023 ESMO 2023 – duelling PD-1 drugs 18 October 2023 ESMO 2023 – Jiangsu Hengrui sets a low bar in KRAS G12D inhibition 18 October 2023 US Keytruda approval scoops one ESMO late-breaker 17 October 2023 ESMO 2023 – Merus gets a pre-meeting boost 17 October 2023 Keytruda’s 25th EU green light 16 October 2023 Load More